FDA Inspection 814115 — Boston Analytical, Inc.

Boston Analytical, Inc. — FEI 1221426

The FDA completed an inspection of Boston Analytical, Inc. on November 9, 2012 in Salem, NH. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
November 9, 2012
Fiscal Year
2013
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Salem, NH (United States)